InsidersTradesSigma
Follow the Novan, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Novan, Inc. has logged 13 public disclosures. Market capitalisation: €5.4bn. The latest transaction was reported on 27 June 2023 (Cession). Among the most active insiders: BIERMAN JAMES L. The full history is openly available.
13
Insider Decl.
n/a
Thresholds
€63,865
6 ops.
Buy Volume
€4,304
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Novan, Inc. Strong Buy (bullish), based on 2 analysts. Average price target: US$175.00.
51Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,603 of 28,752 companies
42.5
score / 100
Value31
Quality54
FCF yld1.0%
Earn yld1.1%
EV/EBITDA30.1x
ROE5.2%
Gross mgn44%
Net mgn5.5%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 June 2023
Declarations13 total
11,553 shares@ US$0.4082100.0% of flowCommon StockSEC:0001467154-23-000073:0
36,101 shares0Common StockSEC:0001467154-23-000062:0
65,000 shares0Common StockSEC:0001467154-23-000065:0
36,101 shares0Common StockSEC:0001467154-23-000063:0
36,101 shares0Common StockSEC:0001467154-23-000064:0
36,101 shares0Common StockSEC:0001467154-23-000061:0
36,101 shares0Common StockSEC:0001467154-23-000060:0
1,000 shares@ US$3.44880.0001% mcap24.9% of flowCommon StockSEC:0001467154-22-000054:0
Canonical exit: 6 Jul 2022 (T+90)
1,000 shares@ US$3.450.0001% mcap24.6% of flowCommon StockSEC:0001467154-22-000047:0
Canonical exit: 26 Jun 2022 (T+90)
2,000 shares@ US$3.5450.0001% mcap50.5% of flowCommon StockSEC:0001467154-22-000045:0
Canonical exit: 23 Jun 2022 (T+90)
10,000 shares@ US$3.6350.0006% mcap68.3% of flowCommon StockSEC:0001467154-22-000043:0
Canonical exit: 16 Jun 2022 (T+90)
1,000 shares@ US$3.500.0001% mcap100.0% of flowCommon StockSEC:0001467154-22-000042:0
Canonical exit: 16 Jun 2022 (T+90)
5,000 shares@ US$3.3370.0003% mcap31.7% of flowCommon StockSEC:0001467154-22-000039:0
Canonical exit: 14 Jun 2022 (T+90)
13 of 13 declarations
About Novan, Inc.
Novan, Inc. is a company focused on developing innovative treatments for dermatological diseases. It specializes in the use of nitric oxide technology for its products.